Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy
Authors
Keywords
Age-related macular degeneration, Polypoidal choroidal vasculopathy, Anti-vascular endothelial growth factor, Aflibercept, Treat-and-extend regimen, Macular thickness, Choroidal thickness, Optical coherence tomography, Fluorescein angiography, And indocyanine green angiography
Journal
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Volume 255, Issue 10, Pages 1891-1897
Publisher
Springer Nature
Online
2017-07-02
DOI
10.1007/s00417-017-3718-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence Rate of Massive Submacular Hemorrhage and its Risk Factors in Polypoidal Choroidal Vasculopathy
- (2016) Joon Hee Cho et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravitreal Aflibercept and Ranibizumab Injections for Polypoidal Choroidal Vasculopathy
- (2016) Han Joo Cho et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathy
- (2016) Wataru Kikushima et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- One-year outcomes of a treat-and-extend regimen of intravitreal aflibercept for polypoidal choroidal vasculopathy
- (2016) Mio Hosokawa et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration
- (2016) Hideki Koizumi et al. OPHTHALMOLOGY
- Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians
- (2016) Chee Wai Wong et al. PROGRESS IN RETINAL AND EYE RESEARCH
- TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT FOR RETINAL ANGIOMATOUS PROLIFERATION
- (2016) Hidetaka Matsumoto et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Treatment Outcomes After 3 Years in Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen
- (2015) Nadim Rayess et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study
- (2015) Hideki Koizumi et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
- (2015) Akiko Yamamoto et al. OPHTHALMOLOGY
- INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY
- (2015) Fumi Gomi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Optimizing the Anti-VEGF Treatment Strategy for Neovascular Age-Related Macular Degeneration: From Clinical Trials to Real-Life Requirements
- (2015) Irmela Mantel Translational Vision Science & Technology
- Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes
- (2014) Sylvie Julien et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration: how to alleviate the clinical burden with maintained functional results
- (2014) C Gianniou et al. EYE
- Short-term efficacy of intravitreal aflibercept for patients with treatment-naïve polypoidal choroidal vasculopathy
- (2014) Shigeyuki Ijiri et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Comparisons of Outcomes With Different Intervals Between Adjunctive Ranibizumab and Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
- (2013) Taku Sato et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
- (2013) K H Patel et al. EYE
- Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity
- (2013) Ryusaburo Mori et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
- (2013) Soraya Rofagha et al. OPHTHALMOLOGY
- One-Year Results of Three Monthly Ranibizumab Injections and As-Needed Reinjections for Polypoidal Choroidal Vasculopathy in Japanese Patients
- (2012) Taiichi Hikichi et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug
- (2012) Michael W Stewart BRITISH JOURNAL OF OPHTHALMOLOGY
- HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
- (2012) Michael A. Singer et al. OPHTHALMOLOGY
- EVEREST STUDY
- (2012) Adrian Koh et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Subfoveal Retinal and Choroidal Thickness After Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
- (2011) Ichiro Maruko et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Predictive factors of resolved retinal fluid after intravitreal ranibizumab for polypoidal choroidal vasculopathy
- (2011) H. Koizumi et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
- (2009) Geeta A. Lalwani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now